Reports and Filings

Investor Information

Find key information for investors – management and investor relations contact details, Auditor, Transfer Agent and SEDAR Profile.

Arch Biopartners is traded on the TSX Venture, listed as ARCH in Canada, and on the OTC market (USA) listed as ACHFF. Delayed stock data for both stock symbols is provided for your information, below.

Subcategories

Press Releases

ARCH Scientist Publishes Paper Showing Pre-Clinical Efficacy of AB569 in Eradicating Multi-Drug Resistant Pathogens Acinetobacter baumannii and Acinetobacter spp

February 26th 2021

Peter Lougheed Centre Joins the Phase II Trial of LSALT Peptide for the Treatment of Complications in Hospitalized COVID-19 Patients

Arch Biopartners

+1 647 428 7031
info@archbiopartners.com
Mailing Address
27 St. Clair Ave East
P.O. Box 305
Toronto, Ontario
Canada M4T 2M5

PAGE TOP | TYPE SIZE | | RESET

Reports and Filings

Investor Information

Stock Performance

Subcategories

ARCH Scientist Publishes Paper Showing Pre-Clinical Efficacy of AB569 in Eradicating Multi-Drug Resistant Pathogens Acinetobacter baumannii and Acinetobacter spp

Peter Lougheed Centre Joins the Phase II Trial of LSALT Peptide for the Treatment of Complications in Hospitalized COVID-19 Patients